| scholarly article | Q13442814 |
| P2093 | author name string | H Lübbert | |
| C Ullmer | |||
| K Schmuck | |||
| P Engels | |||
| P2860 | cites work | High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 |
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes | Q28283410 | ||
| Expression cloning of a rat brain somatostatin receptor cDNA | Q28565466 | ||
| Protein kinase recognition sequence motifs | Q29620224 | ||
| Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition | Q30421359 | ||
| New mouse 5-HT2-like receptor. Expression in brain, heart and intestine | Q30997121 | ||
| 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system | Q34302096 | ||
| The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors | Q34419983 | ||
| Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors | Q34562816 | ||
| cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes | Q34633342 | ||
| A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences | Q36064468 | ||
| Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites | Q38339979 | ||
| 5-HT1C receptor activation: a key step in the initiation of migraine? | Q38727804 | ||
| Synthesis and processing of asparagine-linked oligosaccharides | Q40313039 | ||
| A proposed new nomenclature for 5-HT receptors. | Q40846227 | ||
| Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans | Q41505588 | ||
| The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution | Q49152008 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 85-90 | |
| P577 | publication date | 1994-03-28 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Cloning and functional characterization of the human 5-HT2B serotonin receptor | |
| P478 | volume | 342 |
| Q41533296 | 5-HT receptor classification and nomenclature: towards a harmonization with the human genome |
| Q50298317 | 5-HT2 receptor can bind serotonin |
| Q28303964 | 5-HT2 receptor subtypes: a family re-united? |
| Q24315072 | 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells |
| Q40571185 | 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives |
| Q44759182 | 5-Hydroxytryptamine-induced bladder hyperactivity via the 5-HT2A receptor in partial bladder outlet obstruction in rats |
| Q28142963 | A review of central 5-HT receptors and their function |
| Q34432759 | Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. |
| Q28293653 | Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated |
| Q34425588 | BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats |
| Q33928730 | Behavioral effects of AMI-193, a 5-HT(2A)- and dopamine D(2)-receptor antagonist, in the squirrel monkey |
| Q77951113 | Bradykinin and phorbol ester but not 5-HT2B receptor activation stimulate phospholipase D activity in the rat stomach fundus |
| Q48291979 | Cloning, mRNA localization and evolutionary conservation of a human 5-HT7 receptor pseudogene |
| Q36124822 | Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson's disease |
| Q34264903 | Developmentally regulated serotonin 5-HT2B receptors. |
| Q44513544 | Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment |
| Q43580938 | Dissociation of systemic and hippocampal modulation of rat locomotor activity by 5-HT(2C) receptors |
| Q59201319 | Distribution of 5-HT Receptors in the Central Nervous System |
| Q51126109 | Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety. |
| Q24679647 | Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety |
| Q35884702 | Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine |
| Q28583455 | Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system |
| Q41501087 | Evolutionary conservation of the 5-HT2B receptors. |
| Q28296354 | Expression of serotonin receptor mRNAs in blood vessels |
| Q34391633 | Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects |
| Q41622739 | Functional characteristics of heterologously expressed 5-HT receptors |
| Q24675490 | Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells |
| Q24683135 | Imaging the serotonin transporter during major depressive disorder and antidepressant treatment |
| Q24679694 | In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties |
| Q24671737 | Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505 |
| Q28142235 | Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1 |
| Q73385429 | Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent? |
| Q57910658 | Localization of the gene for the human serotonin 5-HT2Breceptor to chromosome 2 |
| Q40354072 | Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells |
| Q24671497 | Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones |
| Q92538680 | Meta-Analysis of in vitro-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages in vivo |
| Q28210479 | Multiplicity of mechanisms of serotonin receptor signal transduction |
| Q34792193 | On the nature of the 5-HT receptor subtype inhibiting acetylcholine release in the guinea-pig ileum |
| Q24306644 | Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line |
| Q42025199 | Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors |
| Q33863285 | Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease |
| Q24672108 | RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist |
| Q34432766 | SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist |
| Q42061639 | Sequential Astrocytic 5-HT2B Receptor Stimulation, [Ca(2+)]i Regulation, Glycogenolysis, Glutamate Synthesis, and K(+) Homeostasis are Similar but Not Identical in Learning and Mood Regulation |
| Q30663345 | Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. |
| Q34143560 | Serotonin Receptors – From Molecular Biology to Clinical Applications |
| Q41326216 | Serotonin in the regulation of brain microcirculation |
| Q36955654 | Serotonin2A receptor binding potential in people with aggressive and violent behaviour |
| Q30382524 | Structure and function of serotonin G protein-coupled receptors. |
| Q71131045 | Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia |
| Q37849764 | The biological basis of headache |
| Q24322591 | The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors |
| Q33953439 | The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound |
| Q35026883 | The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test |
| Q34663667 | The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis |
| Q24312997 | The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors |
| Q33349223 | Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells |
| Q43945872 | Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration |
Search more.